Could a revision of the current guidelines for cancer drug use improve the quality of cancer treatment?

Lippert, Theodor H.; Volm, Manfred; Ruoff, Hans-Jörg

dc.contributor.author	Lippert, Theodor H.
dc.contributor.author	Ruoff, Hans-Jörg
dc.date.accessioned	2014-07-24T15:29:23Z
dc.date.available	2014-07-24T15:29:23Z
dc.date.issued	2014
dc.identifier.issn	1176-6336
dc.identifier.uri	http://hdl.handle.net/10900/54932
dc.language.iso	en	en
dc.publisher	Dove Medical Press Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.2147/TCRM.S51404	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Could a revision of the current guidelines for cancer drug use improve the quality of cancer treatment?	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140610213910_01135	de_DE
utue.publikation.seiten	69-72	de_DE
utue.personen.roh	Lippert, Theodor H.
utue.personen.roh	Volm, Manfred
utue.personen.roh	Ruoff, Hans-Jörg
dcterms.isPartOf.ZSTitelID	Therapeutics and Clinical Risk Management	de_DE
dcterms.isPartOf.ZS-Volume	10	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE